Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report

Go back to Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report

Agenus Inc. (AGEN) PT Lowered to $7 at Jefferies

March 16, 2021 7:56 AM EDT

Jefferies analyst Biren Amin lowered the price target on Agenus Inc. (NASDAQ: AGEN) to $7.00 (from $8.00) while maintaining a Buy rating.

The analyst commented, "On the Q4 call, mgmt stated that the BLA submission of balstilimab is on track to... More

Agenus (AGEN) Reports Q4 Loss of $0.20/sh

March 15, 2021 7:47 AM EDT

Agenus (NASDAQ: AGEN) reported Q4 EPS of ($0.20), versus ($0.22) reported last year. Revenue for the quarter came in at $31.3 million, versus $34.5 million reported last year.

For earnings history and earnings-related data on Agenus (AGEN) click here.

... More